HSP90B2P and cancer: Several clinical trials are currently evaluating the efficacy of HSP-targeted therapies in combination with existing cancer treatments.[45] Early findings suggest that these approaches could improve treatment response rates and reduce resistance, making them promising candidates for integration into standard cancer therapy.